Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.05
-0.25 (-1.63%)
Dec 15, 2025, 3:10 PM EST - Market open
Janux Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$62.00
Upside
+311.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +152.49% | Dec 2, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +112.62% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $58 → $49 | Strong Buy | Maintains | $58 → $49 | +225.58% | Dec 2, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $150 | Buy | Maintains | $200 → $150 | +896.68% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $45 | Strong Buy | Maintains | $70 → $45 | +199.00% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +365.12% | Nov 25, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| Barclays | Barclays | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +218.94% | Nov 7, 2025 |
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +212.29% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +564.45% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +199.00% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +378.41% | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +179.07% | Aug 19, 2025 |
| Raymond James | Raymond James | Buy Initiates $65 | Buy | Initiates | $65 | +331.89% | Jul 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +365.12% | Mar 3, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $62 → $41 | Hold | Maintains | $62 → $41 | +172.43% | Feb 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.